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Background: Testosterone deficiency is associated with insulin resistance. However, how testosterone deficiency
affects insulin actions remains unclear. The aim of this study was to investigate the influence of castration-induced
testosterone deficiency on the metabolic kinetics of glucose and to evaluate the hepatic and extra-hepatic insulin
sensitivity, in advanced-age male Sprague–Dawley (SD) rats.
Methods: Ten-week-old male SD rats were randomly divided into three groups: (1) a control group (n = 10) in
which the rats underwent sham castration (2) a castrated group (TD group for testosterone deficiency, n = 10) in
which the rats underwent bilateral orchidectomy surgery and (3) a castrated group given testosterone propionate
via intraperitoneal injection (25 mg/kg/day) to supplement androgen (TD + TP group, n = 10). At ten weeks after
castration in the noted groups, all rats were subjected to an oral glucose tolerance test (OGTT), a pyruvate tolerance
test (PTT) and an insulin tolerance test (ITT). Twenty weeks following that treatment, all rats underwent a
hyperinsulinemic-euglycemic clamp procedure in conjunction with isotope–labeled glucose and glycerol tracer
infusions. The rate of appearance (Ra) of glucose, glycerol and gluconeogenesis (GNG), hepatic glucose production
and the rate of glucose disappearance (Rd) were assessed. Glucose uptake was determined by measuring the
2-deoxy-D-14C-glucose in the gastrocnemius muscles.
Results: Ten weeks after castration in the TD group, the fasting blood glucose and insulin levels were
significantly increased (p < 0.01), the glucose– induced insulin secretion was impaired and ITT revealed a temporarily
increased whole body insulin sensitivity compared with the control group; 30 weeks after castration, the Ra of glucose,
Ra of glycerol, as well as the HGP and GNG were also increased (p < 0.01), while the exogenous glucose infusion rate
and uptake glucose in the muscle markedly decreased (p < 0.01).
Conclusions: Castration-induced testosterone deficiency primarily increases fasting blood glucose levels. The clamp
experiments revealed a clear insulin resistance both at the hepatic and extra-hepatic levels.
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Late-onset hypogonadism (LOH) or age-associated testos-
terone deficiency syndrome, which is defined as a clinical
and biochemical syndrome associated with advancing age
and is characterized by symptoms of hypogonadism and
a deficiency in serum testosterone levels, has become a
world-wide concern because it adversely affects the func-
tion of multiple organ systems [1]. Patients with LOH not
only have the symptoms of testosterone deficiency, but
the incidences of metabolic syndrome have also notably
increased [2]. Epidemiological studies have shown a direct
correlation between plasma testosterone and insulin sensi-
tivity, and low testosterone levels are associated with an
increased risk of type-2 diabetes mellitus [3]. Prospective
studies indicated that the risk of type 2 diabetes can be re-
duced by 42% in men with normal testosterone levels [4].
However, clinical intervention studies reported controver-
sial results regarding the effects that testosterone replace-
ment therapy has on insulin resistance in aging males [5].
This controversy is partly due to the lack of long-term
safety and efficacy of testosterone replacement therapy.
Additionally, the mechanism of how testosterone affects
insulin actions remains unclear. Morimoto S et al. [6]
found that testosterone has a direct effect upon pancreatic
islet function by favoring insulin gene expression and re-
lease. Christoffersen B et al. [7] observed that castration-
induced testosterone deficiency in male rats led to insulin
resistance; however, they only describe the parameters
related to the metabolic syndrome. The mechanism of
how testosterone deficiency affects insulin actions and
the metabolic kinetics of glucose has not yet been iden-
tified to date.
Insulin regulates glucose homeostasis through binding
to the extra cellular domain of the insulin receptor in its
responsive target organs such as skeletal muscles, liver
and adipose tissue. When homeostasis is reached, the rate
of glucose appearance (Ra) is equal to that of glucoseFigure 1 Research protocol of the experiment.disappearance (Rd). Endogenous glucose production
(EPG) in the liver and glucose uptakes by skeletal muscles
and adipose tissue are crucial factors that contribute to
the homeostasis of glucose. Glucose uptake by skeletal
muscle accounts for 75 to 80% of normal insulin-
stimulated whole-body glucose disposal after a meal [8].
Hepatic or extra-hepatic insulin resistance leads to ab-
normal EPG, Rd or uptake, which can induce instability
in glucose homeostasis. There is no data demonstrating
how testosterone deficiency affects these parameters.
This study aimed to investigate the influence of testos-
terone deficiency on glucose metabolism kinetics using
the isotope technique in combination with hyperinsuli-




All animal experiments were approved by the Animal
Experimental Ethical Committee, the Ninth People’s Hos-
pital, School of Medicine, Jiao Tong University, Shanghai,
China. The approval data was June 1, 2012 and the Refer-
ence Number was HKDL [2012] 6.
The study comprised 30 male Sprague–Dawley rats
(10 weeks old) that were bred and housed locally at
22+/−2°C under a 12 h on/12 h off light cycle with free
access to food and water. The experiments were per-
formed in conformity with the Guide for the care and use
of laboratory animals published by the US National Insti-
tutes of Health (publication no. 85–23, revised 1996). The
rats were randomly divided into three groups: (1) a con-
trol group (n = 10) in which the rats underwent sham cas-
tration (2) a castrated group (TD group for testosterone
deficiency, n = 10) in which the rats underwent bilateral
orchidectomy surgery and (3) a castrated group given
testosterone propionate via intraperitoneal injection
(25 mg/kg/day) for 30 weeks to supplement androgen
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a normal diet (52% carbohydrate, 22.1% proteins, 9.2%
water, 5.28% fat, 4.12% cellulose, 4.22% mineral salts). The
study ended after 30 weeks after the castration operation.
(Study protocol is shown in Figure 1).
Blood sample assays
Ten weeks after castration, tail blood samples were ob-
tained after an overnight fast to assess glucose, insulin and
testosterone in all rat groups. The plasma glucose concen-
trations were assayed using the Siemens Dimension MAX
(Siemens Healthcare Diagnostics Inc., NY, U.S.A). The
plasma insulin levels were assayed via a magnetic affin-
ity immunoassay (Insulin MPAIA Kit, Bioekon Bio Inc.,
Beingjing, China). The testosterone (T) levels were
assayed via a chemiluminescent Microparticle immuno-
assay (CMIA).
Oral glucose tolerance test (OGTT)
All rats were fasted for 16 h before the test and received
2 g/kg glucose solution via oral gavage. Blood samples
were taken by severing the tip of the tail at 0, 15, 30, 60,
90 and 120 min after glucose administration. Areas under
the curves (AUC) for OGTT were calculated to evaluate
glucose tolerance.
Intraperitoneal insulin tolerance test (ITT)
The rats were fasted for 12 h before the experiments prior
to IP insulin injection (0.75 IU/kg). Blood samples were
collected from the tail at 0, 15, 30 and 60 min for the
serum glucose level measurements. Areas under the curve
for ITT were calculated to evaluate insulin sensitivity.
Pyruvate tolerant test (PTT)
The rats were fasted for 16 h before the test, and a sodium
pyruvate solution (1 g/kg) was IP-injected. The glucose
levels were determined in the blood collected from the tail
at 0, 15, 30, 60, 90 and 120 min after the pyruvateFigure 2 Schematic diagram of the study tracer infusion protocol.injection. The areas under the curve of glycemia vs. time
were calculated to estimate the total glucose synthesized
from pyruvate.
Isotope infusion procedure
Thirty weeks after castration, the rats were fasted over-
night and underwent isotope infusion as we previously
reported [9]. The tail artery was catheterized for blood
collection and established an optimal V-A mode of meta-
bolic experiments. The procedure is shown in Figure 2.
Blood samples were collected at 0, 65 and 70 min.
Hyperinsulinemic euglycemic clamp
The appearance rates of glucose were traced using [6, 6-2D]
glucose, while the gluconeogenesis (GNG) rates were
accessed using [U-13C]-glycerol. The hepatic glucose
production (HGP) and the rate of glucose disappearance
(GRd) of the fasting rats were determined using the
hyperinsulinemic-euglycemic clamp with the continu-
ous infusion of [6, 6-2D] glucose and regular insulin.
The average glucose uptake rates of the gastrocnemius
muscles were also determined via injection of 2-deoxy-
D-14C-glucose.
The studies lasted 165 minutes and included 75 minutes
of a basal clamp phase for the assessment of the basal
glucose turnover and 90 minutes of a hyperinsulinemic-
euglycemic clamp phase for the evaluation of insulin
sensitivity. One blood sample was obtained immediately
prior to starting the tracer infusion to determine the
background glucose enrichment and insulin concen-
tration in the plasma. The [6,6-2D] glucose (at a rate
of 2 μmol/kg/min) and [U-13C]-glycerol (at rate of
0.84 μmol/kg/min) were then constantly infused intra-
venously via the IV infusion line driven using a Harvard
mini infusion pump (Harvard Apparatus, Holliston, MA,
U.S.A.) for 75 minutes (basal period). Blood was sampled
prior to tracer infusions and at 65, 70, and 75 min. While
the [6,6-2D] glucose infusion continued, a primed and
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lin (5 mIu/kg/min, Novolin R, Novo Nordisk, Denmark)
was initiated for another 90 min (chase period). The
plasma glucose concentration was maintained at the basal
level by monitoring the plasma glucose every 10 minutes
and empirically adjusting the infusion rate of a 25% glu-
cose solution. Twenty minutes prior to the end of the
chase period, 1 μCi of 2-deoxy-D-14C-glucose (PerkinElmer,
Waltham, U.S.A.) was injected through the IV infusion
line for the measurement of tissue glucose uptake. During
the final 10 minutes, 3 additional blood samples were
collected at 3-minute intervals. A flow chart of the study
design is shown in Figure 2. The rats were euthanized
via cardiac puncture under anesthesia with chloral hy-
drate (5 mg/kg) to reduce blood elements in tissues.
The gastrocnemius muscle was immediately biopsied,
cut into small pieces, immersed in liquid nitrogen and
stored at -80°C. The plasma samples were prepared on
ice, centrifuged at 4°C, separated and stored at -80°C
until further analysis.Gas Chromatography/Mass Spectrometry
Enrichments of the glycerol and glucose were mea-
sured using GC-MS with their trimethylsilyl derivative
via methoxyamine-HCl and BSTFA to obtain m/z: 321/
319 [6, 6-2D] glucose and m/z: 221/218 [U-13C]-glycerol.
The GC was equipped with a DB-5MS capillary column
(30 m × 0.25 mm inner diameter, 0.25 ìm film). The GC
oven temperature was programmed initially at 70°C for
4 min, increased to 240°C at 10°C /min and then to 300°C
at 20°C /min and sustained at 300°C for 11 min. The
GC was electronically controlled for constant pressure
and humidity.Table 1 The body weight, blood glucose, testosterone
and estrogen levels of the three groups of rats at the end
of the study (+/−s)
C TD TD + TP P
value(n = 10) (n = 10) (n = 10)
Body weight (g) 629+/−66.93 502.86+/−66.88* 546+/−44.63* 0.0188
RBG (mmol/L) 4.46+/−1.08 5.36+/−0.67 4.98+/−0.438 0.1696
FBG (mmol/L) 4.56+/−1.173 5.514+/−0.705*# 3.34+/−1.171 0.0082
T (ng/mL) 2.96+/−0.55 1.45+/−0.26*# 2.07+/−0.35* 0.0053
E2 (pg/mL) 8.2+/−2.08 6.4+/−2.05 8.4+/−1.52 0.065
C, control group, rats underwent sham surgery; TD, testosterone deficiency
group, rats underwent bilateral orchidectomy surgery; TD + TP, castrated rats
given testosterone; RBG, random blood glucose; FBG, fasting blood glucose; T,
testosterone; E2, estrogen; Data are presented as the means +/− SD.
*, compared with the control group (C).
#, compared with castrated rats replaced with testosterone
propionate (TD + TP).Calculation
The infusion rates (ìmol/kg/min) of [U-13C]-glycerol and
[6, 6-2D] glucose were divided using the MPE of plasma
glycerol and glucose, respectively, to obtain the appear-
ance rate (ìmol/kg/min) [10].
Raglu (ìmol/kg/min) = HGP = infusion rate of [6, 6-2D]
glucose (ìmol/kg/min)/ MPE of plasma glucose.
Ragly (ìmol/kg/min) = infusion rate of [U-13C]-glycerol
(ìmol/kg/min)/MPE of plasma glycerol –infusion rate of
[U-13C]-glycerol (ìmol/kg/min).
The gluconeogenesis rates were calculated by dividing
the MPE of the plasma [U-13C]-glycerol by the MPE
of the [1, 2, 3-13C] glucose. In this experiment, appre-
ciable amounts of [U-13C]-glycerol were converted to
[1, 2, 3-13C] glucose via gluconeogenesis. Thus, we could
compare the gluconeogenesis rates between different
groups [11].
The gluconeogenesis rates =MPE of [1, 2, 3-13C]
glucose/MPE of plasma [U-13C]-glycerol.GNG from glycerol (ìmol/kg/min) = percent of Raglu
(ìmol/kg/min).
Percent of glycerol converted to glucose = Ragly (ìmol/
kg/min) * MPE of [1, 2, 3-13C] glucose/infusion rate of
[U-13C]-glycerol (ìmol/kg/min).
The average glucose uptake rates of the gastrocnemius
muscles were calculated as follows [12]:
Glucose uptake (ìmol/g/min) =muscle 2-deoxy-D-14C-
glucose radioactivity (dpm/g/min)/plasma 2-deoxy-D-
14C-glucose SA (dpm/ìmol).
Statistical analysis of data
All values were expressed as the means+/−SD. Statistical
significances were evaluated using ANOVA. P values < 0.05
indicated a significant difference.
Results
Body weight and blood glucose levels
Prior to the bilateral orchidectomy surgery, there were
no differences in body weight or random and fasting
blood glucose levels between the three groups of rats (data
not shown). At the completion of the study, the mean
body weight in the control group was significantly higher
than those in the TD group and TD+TP group. The
mean body weight was also slightly higher in the TD +TP
group than in the TD group, but without statistical
significance (control group: 629.2+/−66.93 g, TD group:
502.86+/−66.88 g TD + TP group: 546+/−44.63 g,
P = 0.0188) (Table 1).
When compared with the control group and the TD +
TP group, the random blood glucose levels of the TD
group increased slightly (control group: 4.46+/−1.08 mmol/
L, TD group: 5.36+/−0.67 mmol/L, TD + TP group:
4.98+/−0.438 mmol/L, P = 0.1696), while the fasting
blood glucose levels were significantly higher (control group:
4.56+/−1.173 mmol/L, TD group: 5.514+/−0.705 mmol/L,
TD+TP group: 3.34+/−1.171 mmol/L, P = 0.0082) (Table 1).
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Following castration, the serum testosterone levels
were significantly lower compared with those in the rat
control group (TD group: 1.45+/−0.26 ng/ml, control
group: 2.96+/−0.55 ng/ml, p < 0.05); testosterone propionate
replacement partially raised the levels. The concentrations
of estrogen were not significantly different between
those in the castrated and non-castrated rats (Table 1).
Fasting plasma insulin (FINS), Homeostasis model-Insulin
resistance (HOMA-IR) and Insulin sensitivity index (ISI)
The FINS concentrations in the TD group were signifi-
cantly higher than those in the control group and the
TD + TP group, while those in the control group signifi-
cantly lower than those in the TD+TP group (control
group: 6.39+/−0.83 μIu/ml, TD group: 13.61+/−2.785 μIu/
ml, TD + TP group: 9.66+/−1.04 μIu/ml, P = 0.0036).
The HOMA-IR, an index of insulin resistance, was
significantly higher in the TD group compared with
the control and the TD + TP groups (control group:
1.172+/−0.155, TD group: 2.796+/−0.299, TD + TP group:
1.745+/−0.177, P < 0.0001). The insulin sensitivity index
was the opposite, as that in the TD group and TD + TP
group were lower than that in the control group
(control group: -3.086+/−0.122, TD group: -4.013+/−0.215,
TD+TP group: -3.624+/−0.119, P = 0.0003) (Figure 3).
The effect of testosterone deficiency on whole body
insulin sensitivity
Ten weeks after the surgery, the fasting glucose levels in
the TD group were slightly and not significantly higher
compared with controls. An analysis of the OGTT re-
vealed that castration had no significant effect on glucose
intolerance following glucose challenge and that the AUCs
of OGTT in all groups were similar (Figure 4A). The
rats in the TD group exhibited significantly lower serum
insulin levels in response to oral glucose administrationFigure 3 FINS, HOMA-IR and ISI of the three groups.
Insulin concentration and HOMA-IR increased dramatically with a
decrease in the insulin sensitivity index. *, compared with control
group (C). #, compared with castrated rats replaced with testosterone
propionate (TD + TP).in spite of higher fasting levels, while in the controls
these levels increased dramatically (Figure 4D). Whole-
body insulin sensitivity was assessed by performing in-
sulin tolerance tests. ITT revealed that rats in the TD
group had significantly less glucose in circulation after
insulin treatment than the controls. Similarly, The AUC
of ITT in the TD group was also significantly lower than
that in the control and TD + TP groups (Figure 4C). We
investigated whether testosterone deficiency induced an
impairment of gluconeogenesis, which could contribute
to the pathophysiological production and clearance of
glucose. To this end, the gluconeogenic substrate pre-
cursor pyruvate was administered to the three rat groups
(pyruvate tolerance test, PTT). The PTT measured the
extension of the whole-body conversion of pyruvate
into glucose and allowed for the assessment of the
rate of gluconeogenesis, which was an important com-
ponent of HGP. We found that the rats in the TD group
had increased glucose production compared with controls
(Figure 4B).
Glucose appearance rates at the basal period
After overnight fasting, the glucose appearance rates
in the TD group were significantly higher compared
with those in the control and TD + TP groups (TD
group: 80.11+/−18.53 μmol/kg/min, control group:
52.30+/−11.37 μmol/kg/min, TD + TP group: 57.67+/−
3.81 μmol/kg/min, P = 0.0087) (Figure 5A).
Glycerol appearance and gluconeogenesis (GNG)
The glycerol appearance after overnight fasting was
higher in the TD group than those in control group and
TD + TP group (TD group: 39.99+/−7.70 μmol/kg/min,
control group: 18.52+/− 6.72 μmol/kg/min, TD + TP
group 21.26+/−9.00 μmol/kg/min, P = 0.0009) (Figure 6A).
The parameters of the gluconeogenesis from glycerol in-
cluding glycerol converted to glucose (%), glucose derived
from glycerol (%) and gluconeogenesis from glycerol were
remarkably higher in the TD group than those in the
control group and TD + TP group (glucose derived from
glycerol, TD: 19.96+/−7.74%, control: 10.52+/−3.75%,
TD + TP: 15.23+/−3.81%, P < 0.05) (Figure 6B); gluco-
neogenesis from glycerol: (TD: 6.57+/−1.78 μmol.kg-1.
min-1, control: 4.28+/−0.711 μmol.kg-1.min-1, TD + TP:
5.54+/−1.077 μmol.kg-1.min-1, P < 0.05) (Figure 6C); gly-
cerol converted to glucose (%): (TD: 19.41+/−6.92%,
control: 10.19+/−2.95%, TD +TP: 14.85+/−2.41%, P < 0.05)
(Figure 6D).
Concentrations of blood glucose and insulin at the clamp
steady-state
After exogenous insulin infusion (5 mIu/kg/min) for
90 minutes, the concentrations of blood glucose at clamp
steady-state were similar among the three rat groups.
Figure 4 OGTT, ITT and PTT of the three groups. Oral glucose tolerance test and AUC of OGTT (A), Pyruvate tolerance test and AUC of PTT (B),
Insulin tolerance test and AUC of ITT (C), Glucose-stimulated insulin secretion (D). *, P <0.05 compared with the control group. #, P <0.05 compared
with the TD + TP group.
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Figure 5 HGP and the disappearance rate of glucose (GRd) in the basal state and hyperinsulinemic-euglycemic clamping steady-state.
A: HGP, B: GRd. *,P < 0.05, compared with the control group.
#, P < 0.05, compared with the TD + TP group.
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in the TD group were significantly higher than those in
the control group but lower than those in the TD + TP
group (TD: 15.91+/−2.97 μIu/ml, control: 10.92+/−5.39
μIu/ml, TD + TP: 17.02+/−5.48 μIu/ml) (Figure 7B).
During the same period, the insulin concentrations of
the three groups during the hyperinsulinemic-euglycemic
clamp were dramatically elevated compared with their
basal state. Similarly, the insulin concentration of theFigure 6 Glycerol parameters in the three groups. The glycerol appeara
with the control group and TD + TP group. (A) The parameters of gluconeo
glucose derived from glycerol (%) and gluconeogenesis from glycerol was
groups (B, C, D). *, P < 0.05, compared with the control group. #, P < 0.05, cTD group was significantly higher than that of control
group but lower than that in the TD + TP group (TD:
62.62+/−12.22 μIu/ml, control: 31.23+/−15.62 μIu/ml,
TD + TP: 105.20+/−35.85 μIu/ml) (Figure 7A).
Hepatic glucose production (HGP)
Despite higher insulin concentrations, the HGP follow-
ing overnight fast remained higher in the TD group
than in the control group (80.11+/−16.55 μmol/kg/min,nce after an overnight fast was higher in the TD group compared
genesis from glycerol such as glycerol converted to glucose (%),
higher (p < 0.05) in the TD group than in the control and TD + TP
ompared with the TD + TP group.
Figure 7 Glucose and insulin concentrations in the basal state and hyperinsulinemic-euglycemic clamping steady-state. A: insulin levels,
B: glucose levels. *, P < 0.05, compared with the control group. #, P < 0.05, compared with the TD + TP group.
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atic insulin resistance in the testosterone defective group.
This finding was further confirmed during the exogen-
ous insulin infusion when the endogenous insulin secre-
tion was suppressed in all groups. Under these conditions,
HGP remained greater (p < 0.01) in the TD group than
in the control group (46.17+/−10.18 μmol/kg/min,
10.30+/−3.32 μmol/kg/min) (Figure 5A).
Glucose disappearance rates at the clamp steady-state
After the exogenous insulin infusion (5 mIuU/kg/min)
for 90 minutes, the glucose disappearance rate in the con-
trol group increased from 52.30+/−11.37 μmol/kg/min
(the basal) to 72.49+/−14.12 μmol/kg/min (the steady
state); in the TD group of rats, the glucose disappear-
ance rate increased from 80.11+/−18.5 μmol/kg/min
to 107.80+/−20.24 μmol/kg/min (p < 0.01), while in the
TD +TP group, the glucose disappearance rate increased
from 34.67+/−3.82 μmol/kg/min to 70.86+/−10.15 μmol/
kg/min (P < 0.05). The growth rates of the three groups
were 38%, 34% and 106%, respectively. Under theFigure 8 Exogenous glucose infusion rates (GIR) and muscle glucose
steady-state. A: GIR. B muscle glucose uptake during the hyperinsulinem
control group. #, P < 0.05, compared with the TD + TP group.hyperinsulinemic-euglycemic clamp, the increment in the
TD group was smaller than in the control and TD+TP
groups (Figure 5B).
Glucose infusion rates and Glucose uptake in muscle
The exogenous glucose infusion rates required to main-
tain the glucose levels at the clamp point (6 ~ 7 mmol/L)
were significantly reduced in the TD group; while in
TD + TP group, they were higher than those in con-
trol group (TD: 45.69+/−8.73 μmol/kg/min, control:
62.306+/−18.55 μmol/kg/min, TD+TP: 82.94+/−14.46 μmol/
kg/min), demonstrating insulin resistance in castrated rats
(Figure 8A). The glucose uptake in the gastrocnemius was
significantly lower in the TD group compared with that in
the control and TD+TP groups (TD: 0.245+/−0.065 μmol/
kg/min, control: 0.563+/−0.199 μmol/kg/min, TD+TP:
0.4574+/−0.025 μmol/kg/min, P < 0.05) (Figure 8B).
Discussion
Testosterone changes body compositions and is posi-
tively correlated with lean mass and inversely correlateduptake during the hyperinsulinemic-euglycemic clamping
ic-euglycemic clamping steady-state. *,P < 0.05, compared with the
Xia et al. Reproductive Biology and Endocrinology 2013, 11:106 Page 9 of 11
http://www.rbej.com/content/11/1/106with fat mass in men. The effect that testosterone has
on body weight varies between species. Smith et al. [13]
reported that the mean body weight increased by 1.8%
and fat mass by 11.0% after 12 months of ADT for pa-
tients with non-metastatic prostate cancer. The weight
of the neutered male cats was 18.4% greater than the en-
tire males over a period of 3 months and neutered dogs
were found to be more likely to be overweight; however,
castrated mice had less weight gain than uncastrated
mice [14]. In this study, we found that rat body weight
decreased after castration, and the final body weights
were less than those of the control group. Testosterone
reduction due to castration may have caused the weight
loss due to loss of muscle and bone mass [15]. Despite a
total weight loss, there was a visceral fat aggregation in
the castrated rats. HE staining showed that the liver tis-
sues were steatotic and that the muscle cells had intra-
cellular fat in the castrated rats (pictures not shown).
Castrated rats are accepted model for studying the
androgen deficiency in hypogonadal men [16]. As ex-
pected, the testosterone levels of the castrated rats in
our study were significantly reduced while testosterone
replacement therapy significantly raised the testosterone
levels. Similar results were obtained by other studies
whereby orchiectomy had caused 50% reduction in serum
testosterone in male rats [17], while testosterone replace-
ment was able to raise the testosterone levels [18].
Ten weeks after castration, we found that the baseline
insulin concentrations in castrated rats were higher than
those in normal rats, which conformed to the results in
non-diabetic men [19,20]. However, glucose-stimulated
insulin secretion while OGTT revealed that after glucose
gavage, the increased insulin secretion rate was lower in
the castrated rats. Moreover, the fasting glucose levels as
well as the AUCs of PTT were slightly higher in the TD
group, which indicated that there was a slight hepatic in-
sulin resistance in the castrated rats. Interestingly, the
OGTT in these rats were normal, and the ITT indicated
that the castrated rats had increased their whole body
insulin sensitivity. We think that this change was a com-
pensatory process. These data suggested that in some
stage of testosterone deficiency when glucose tolerance
was normal while stimulated insulin secretion was
undermined, the whole body insulin sensitivity slightly
increased in order to maintain the normal blood glucose
level. One possible mechanism for this might be hypera-
diponectinemia according to the study of Nishizawa H
et al. [21] who found that in rodents the serum testoster-
one level was inversely related to the serum adiponectin
level, an insulin-sensitizing adipocyte-derived protein.
Insulin resistance (IR) can be central (hepatic) or per-
ipheral (muscle, fat) depending on the primary site of in-
volvement. Peripheral insulin resistance impairs glucose
uptake from the blood into muscles (postabsorptive andfasting states), while hepatic IR manifests as unrestrained
glucose production by the liver under fasting conditions
[22]. HOMA-IR and ISI are frequently used to describe
insulin sensitivity in many studies on testosterone defi-
ciency. However, it is difficult to determine the primary site
involved. The euglycemic-hyperinsulinemic clamp tech-
nique combined with isotope traces would assist in deter-
mining the source of the appearance and disappearance of
plasma glucose metabolism. This combined technique
could assist in accurately examining the metabolic flux
of the carbohydrate by measuring the hepatic glucose
production and glucose uptake in the periphery (to dir-
ectly demonstrate insulin resistance).
Hepatic insulin resistance recently received increasing
attention. Gluconeogenesis is a major source of fasting
EGP, which maintains the body's fasting blood glucose at
normal levels [23,24]. In diabetic patients, an increased
gluconeogenesis from a substrate such as glycerol or ala-
nine is the primary cause of hepatic insulin resistance.
In this study, we used U-13C-glycerol to trace the natur-
ally occurring metabolism kinetics of glycerol in the rat
groups. Glycerol is a distinctive precursor of gluconeo-
genesis substrate, which often comes from peripheral tri-
glyceride. We found that the glycerol appearance rates
and gluconeogenesis (including glycerol converted to
glucose (%) and gluconeogenesis from glycerol) were sig-
nificantly higher in the castrated rats, while in castrated
rats treated with testosterone propionate via intraperito-
neal injection (25 mg/kg/day) for 30 weeks, they were
reduced. At fasting, peripheral adipose tissue degrad-
ation is the primary source of glycerol. Due to the lack
of glycerokinase in the adipose tissue, the glycerol released
from it via lipolysis cannot resynthesize. Therefore, the
glycerol appearance rate in the blood is a reliable indicator
for lipolysis [25]. The high levels of glycerol appearance
rates and gluconeogenesis in castrated rats suggested an
increased lipolysis and hepatic insulin resistance. Our
results also demonstrated significantly higher glucose
appearance rates in the TD group compared with those
in control rats. Thus, the absorption of glucose from the
gastrointestinal system was limited when testosterone
was deficient. Testosterone replacement therapy could
partly relieve these metabolic disturbances.
Under hyperinsulinemic conditions, the HGP in the
control group of rats at steady-state was nearly completely
suppressed by insulin (suppressed to 19%); the castrated
group showed a less dramatic decrease, only suppressed
to 58%, which indicated hepatic insulin resistance. To
maintain the clamp glucose level, the exogenous glucose
infusion rates increased by nearly 27% in the control rats
compared with those in the TD rats.
There is increasing awareness of the importance of
muscle as a central player in adapting to excessive
energy input (as it is one of the main fuel-consuming
Xia et al. Reproductive Biology and Endocrinology 2013, 11:106 Page 10 of 11
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of metabolically active tissues of the body. Selective
impairment of glucose disposal by muscle could con-
tribute to the genesis of hyperglycemia and hence
hyperinsulinemia. Approximately 80%-90% of exogenous
glucose infusion is uptaken by the skeletal muscle [27],
and it accounted for up to 70% of the whole body’s insulin
sensitivity. In this study, we use carbon 14 labeled
2-deoxy-glucose to trace the glucose uptake rates of
gastrocnemius under the clamp steady state. 2-deoxy-
glucose has nearly the same feature as normal glucose,
and it can be uptaken by animal tissues and phosphory-
lated to form 6-P-glucose in the cells without further
metabolism. It is a good indicator for measuring the glu-
cose uptake ability in target tissues as a classic method
[28]. The average glucose uptake rates of gastrocnemius
were lowest in the TD group. The replacement of testos-
terone propionate could partly increase the glucose uptake
rates by gastrocnemius, but the rate could not reach the
control levels.
In all, this study showed that castration-induced tes-
tosterone deficiency not only significantly enhances the
hepatic gluconeogenesis but also significantly decreases
extra-hepatic insulin sensitivity in advanced-aged male
rats. The molecular mechanism how these occurred was
still unidentified. Forkhead box protein O1 (FoxO1) has
emerged as an important player in integrating insulin sig-
naling to downstream target gene expression in carbohy-
drate metabolism. Moreover, Testosterone deficiency was
commonly associated with conditions inducing muscle
wasting. Akt signaling could control skeletal muscle mass
through FoxO regulation of protein degradation, and this
pathway have been previously identified as a target of
androgen signaling. By immunohistochemical staining,
we found that the FoxO1 protein expression increased
and migrated into the nucleus in liver, skeletal muscle
and pancreatic tissues in castrated rats (data were sort-
ing for another paper).Conclusions
Castration-induced testosterone deficiency primarily affects
fasting blood glucose and leads to increased levels of fasting
glucose. Low testosterone levels not only significantly
enhance the hepatic gluconeogenesis but also significantly
decrease extra-hepatic insulin sensitivity in male rats.Abbreviations
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